Hypertension, microalbuminuria and renal dysfunction: The Renal Dysfunction in Hypertension (REDHY) study

Journal of Nephrology

Volumn 21, Issue 3, 2008, Pages 368-373

  Cerasola, Giovanni ^a,b   Mulè, Giuseppe ^a   Cottone, Santina ^a   Nardi, Emilio ^a   Cusimano, Paola ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b NONE   (Italy)

Author keywords

Arterial hypertension; Estimated glomerular filtration rate; Renal dysfunction

Indexed keywords

ALBUMIN; CREATININE;

ADULT; ALBUMINURIA; ARTICLE; CREATININE CLEARANCE; DISEASE SEVERITY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; KIDNEY DYSFUNCTION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; URINALYSIS; URINARY EXCRETION; KIDNEY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; URINE;

ALBUMINURIA; CREATININE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; KIDNEY; MALE; MIDDLE AGED; RENAL INSUFFICIENCY;

EID: 52049125776     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Perera GA. Hypertensive vascular disease: description and natural history. J Chronic Dis. 1955;1:33-42.
2. US Renal Data System. USRDS 2005 Annual Data Report. Bethesda, MD (USA): National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2005.
3. Hsu CY, McCulloch CE, Darbinian J, Go AS, Iribarren C. Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease. Arch Intern Med. 2005;165:923-928.
4. Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension. 2003;42:1050-1065.
5. Henry RM, Kostense PJ, Bos G, et al. Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study. Kidney Int. 2002;62:1402-1407.
6. Ruilope LM, Salvetti A, Jamerson K, et al. Renal function and intensive lowering of blood pressure in hypertensive participants of the Hypertension Optimal Treatment (HOT) study. J Am Soc Nephrol. 2001;12:218-225.
7. Rahman M, Brown CD, Coresh J, et al; Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group. The prevalence of reduced glomerular filtration rate in older hypertensive patients and its association with cardiovascular disease. Arch Intern Med. 2004;164:969-976.
8. de Leeuw PW, Ruilope LM, Palmer CR, et al. Clinical significance of renal function in hypertensive patients at high risk. Arch Intern Med. 2004;164:2459-2464.
9. Hailpern SM, Cohen HW, Alderman MH. Renal dysfunction and ischemic heart disease mortality in a hypertensive population. J Hypertens. 2005;23:1809-1816.
10. Cerasola G, Cottone S, Mulè G, Nardi E, Mangano MT, Andronico G. Microalbuminuria, renal dysfunction and cardiovascular complication in essential hypertension. J Hypertens. 1996;14:915-920.
11. Mulè G, Cottone S, Vadalà A, et al. Relationship between albumin excretion rate and aortic stiffness in untreated essential hypertensive patients. J Intern Med. 2004;256:22-29.
12. Cottone S, Vadalà A, Mangano MT, et al. Endothelium-derived factors in microalbuminuric and nonmicroalbuminuric essential hypertensives. Am J Hypertens. 2000;13:172-176.
13. Cottone S, Mulè G, Nardi E, et al. Microalbuminuria and early endothelial activation in essential hypertension. J Hum Hypertens. 2007;21:167-172.
14. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2007 guidelines for the management of arterial hypertension. J Hypertens. 2007;25:1105-1187.
15. Rose BD. Clinical assessment of renal function. In: Rose BD, ed. Pathophysiology of Renal Disease. 2nd ed. New York (USA): McGraw-Hill; 1987:1-23.
16. Levey AS, Greene T, Kusek J, Beck G. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol. 2000;11:155A.
17. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
18. Rule AD, Larson TS, Bergstralh EJ, Slezak JF, Jacobsen SJ, Cosio FG. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med. 2004;141:929-937.
19. Vervoort G, Willems HL, Wetzels JF. Assessment of glomerular filtration rate in healthy subjects and normoalbuminuric diabetic patients: validity of a new (MDRD) prediction equation. Nephrol Dial Transplant. 2002;17:1909-1913.
20. Rule A, Jacobsen S, Schwartz G, et al. A comparison of serum creatinine-based methods for identifying chronic kidney disease in hypertensive individuals and their siblings. Am J Hypertens. 2006;19:608-614.
21. Verhave JC, Gansevoort RT, Hillege HL, De Zeeuw D, Curhan GC, De Jong PE. Drawbacks of the use of indirect estimates of renal function to evaluate the effect of risk factors on renal function. J Am Soc Nephrol. 2004;15:1316-1322.
22. Poggio ED, Wang X, Greene T, Van Lente F, Hall PM. Performance of the Modification of Diet in Renal Disease and Cockcroft-Gault equations in the estimation of GFR in health and in chronic kidney disease. J Am Soc Nephrol. 2005;16:459-466.
23. Coresh J, Byrd-Holt D, Astor BC, et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol. 2005;16:180-188.
24. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1-12.
25. De Zeeuw D, Hillege HL, de Jong PE. The kidney, a cardiovascular risk marker and a new target for therapy. Kidney Int. 2005;68(suppl 98):S25-S29.